1. Home
  2. DCTH vs NVTS Comparison

DCTH vs NVTS Comparison

Compare DCTH & NVTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCTH
  • NVTS
  • Stock Information
  • Founded
  • DCTH 1988
  • NVTS 2014
  • Country
  • DCTH United States
  • NVTS United States
  • Employees
  • DCTH N/A
  • NVTS N/A
  • Industry
  • DCTH Medical/Dental Instruments
  • NVTS Semiconductors
  • Sector
  • DCTH Health Care
  • NVTS Technology
  • Exchange
  • DCTH Nasdaq
  • NVTS Nasdaq
  • Market Cap
  • DCTH 518.0M
  • NVTS 535.2M
  • IPO Year
  • DCTH N/A
  • NVTS N/A
  • Fundamental
  • Price
  • DCTH $14.88
  • NVTS $3.17
  • Analyst Decision
  • DCTH Strong Buy
  • NVTS Strong Buy
  • Analyst Count
  • DCTH 4
  • NVTS 7
  • Target Price
  • DCTH $22.25
  • NVTS $4.39
  • AVG Volume (30 Days)
  • DCTH 356.0K
  • NVTS 3.6M
  • Earning Date
  • DCTH 03-06-2025
  • NVTS 02-24-2025
  • Dividend Yield
  • DCTH N/A
  • NVTS N/A
  • EPS Growth
  • DCTH N/A
  • NVTS N/A
  • EPS
  • DCTH N/A
  • NVTS N/A
  • Revenue
  • DCTH $22,644,000.00
  • NVTS $91,381,000.00
  • Revenue This Year
  • DCTH $1,672.40
  • NVTS $8.34
  • Revenue Next Year
  • DCTH $116.33
  • NVTS $5.50
  • P/E Ratio
  • DCTH N/A
  • NVTS N/A
  • Revenue Growth
  • DCTH 945.91
  • NVTS 38.99
  • 52 Week Low
  • DCTH $3.70
  • NVTS $1.75
  • 52 Week High
  • DCTH $16.97
  • NVTS $7.40
  • Technical
  • Relative Strength Index (RSI)
  • DCTH 46.47
  • NVTS 50.17
  • Support Level
  • DCTH $15.50
  • NVTS $2.68
  • Resistance Level
  • DCTH $16.43
  • NVTS $3.62
  • Average True Range (ATR)
  • DCTH 0.72
  • NVTS 0.24
  • MACD
  • DCTH -0.25
  • NVTS 0.05
  • Stochastic Oscillator
  • DCTH 2.79
  • NVTS 52.13

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.

About NVTS Navitas Semiconductor Corporation

Navitas Semiconductor Corp develops ultra-efficient gallium nitride (GaN) semiconductors that are revolutionizing power electronics. GaN power ICs integrate GaN power with drive, control, and protection to enable fast charging, high power density, and energy savings for mobile, consumer, enterprise, eMobility, and new energy markets. The company operates as one reportable segment, the design, development, manufacture, and marketing of integrated circuits and related components for use in mobile device and other markets. Geographically, the company operates in China, Europe, United States, Rest of Asia and Others. The majority of revenue is generated from China.

Share on Social Networks: